← Open Payments lookup

SAM SAFAEE: Open Payments

NPI 1609172030 · SANTA MARIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$654 in 30 payments from 9 companies in 2025. Trend: 2023 $84 · 2024 $294 · 2025 $654

Food & beverage: $654
CompanyPaymentsAmount
ABBVIE INC.17$190
Sumitomo Pharma America, Inc.1$111
Tris Pharma Inc2$93
Vanda Pharmaceuticals Inc.3$67
Supernus Pharmaceuticals, Inc.2$66
Alkermes, Inc.2$56
Lundbeck LLC1$27
Otsuka America Pharmaceutical, Inc.1$23
Almatica Pharma LLC1$21

Products named: VRAYLAR, GEMTESA, Dyanavel XR, FANAPT, Qelbree, ARISTADA, ABILIFY ASIMTUFII, LOREEV XR.

Industry payments across CA — which companies pay providers there.